Advisortrust Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Advisortrust Partners's AMGN Position: Q2 2026 in Review
Advisortrust Partners reduced its Amgen (AMGN) stake by 94% in Q2 2026, selling an estimated $3.86M and leaving 719 shares worth $260K. The position accounts for 0.09% of the portfolio, ranked #168.
Advisortrust Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.22M in Q1 2026. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Advisortrust Partners held 719 shares of Amgen worth $260K as of Q2 2026.
- Advisortrust Partners sold 11,282 Amgen shares in Q2 2026, an estimated $3.86M.
- Amgen made up 0.09% of Advisortrust Partners's portfolio in Q2 2026, its #168 holding.
- Advisortrust Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- Advisortrust Partners's Amgen position peaked at $4.22M in Q1 2026.
- 3,132 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Advisortrust Partners's 13F filing for Q2 2026, filed 10 Aug 2026.